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Abstract
Background: Hyperparasitaemia is a feature of childhood severe malaria but there is little information on the risk
factors for hyperparasitaemia in malarious children
Methods: The risk factors associated with Plasmodium falciparum hyperparasitaemia, defined as asexual
parasitaemia > 250,000/μl, at presentation were evaluated in 3338 malarious children enrolled prospectively
between 2008 and 2010 in an endemic area of southwestern Nigeria.
Results: At enrolment, 97 (3%) of 3338 malarious children had hyperparasitaemia. In a multiple regression model, 3
factors were found to be independent risk factors for the presence of hyperparasitaemia at enrolment: an age ≤ 11
years (Adjusted odds ratio [AOR] = 2.85, 95% confidence interval [CI] 1.23-6.61, P = 0.014), fever (AOR = 2.02, 95%
CI 1.23-3.29, P = 0.005), and enrolment after year 2008 (AOR = 0.42, 95% CI 0.24-0.73, P = 0.002). Duration of illness
≤ 3 d was associated with increased risk of hyperparasitaemia. There was no association between season and
hyperparasitaemia. Compared to non-hyperparasitaemia, hyperparasitaemia was associated with an increased risk of
progression to cerebral malaria (P < 0.0001). The risk of progression in hyperparasitaemic children was higher in <
5-year olds (P = 0.02).
Conclusion: Young age and presence of fever are independent risk factors for hyperparasitaemia which is
associated with an increased risk of progression to cerebral malaria. The findings have implications for case and
community management of childhood hyperparasitaemia and for malaria control efforts in sub-Saharan Africa
where severe malaria is relatively common.
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Background
Plasmodium falciparum hyperparasitaemia, defined as >
250,000 asexual parasites/μl blood or > 4% parasitized
erythrocytes [1,2], is a feature of severe childhood
malaria, is indicative of a large sequestered parasite bio-
mass, and poses a risk for recrudescent infections follow-
ing antimalarial drug treatment [3,4]. Hyperparasitaemia
is relatively more frequent in the relatively non-immune
individuals [1] but may also occur in semi-immune popu-
lations with much variability in clinical features [5]. How-
ever, in some non-endemic populations, for example in
Indian children, it is associated with increased risk of
mortality [6].
Delay in parasite clearance by all antimalarial drugs is
associated with increasing parasitaemia and hyperparasi-
taemia [4,7] and is thought to be contributory to drug
treatment failure in P. falciparum to antimalarials includ-
ing artemisinin derivatives and artemisinin-based combi-
nations [8]. A recent study from Thailand [9], an area of
lesser intensity of malaria transmission than Nigeria [10],
has shown that hyperparasitaemia is a risk factor for
gametocyte carriage. Although hyperparasitaemia is fre-
quently reported in many antimalarial and malaria stu-
dies there is little or no information on the risk factors
for hyperparasitaemia in childhood falciparum infections.
Such information is necessary as it may potentially har-
ness the efforts aimed at the management and control of
drug resistance in both the individual and the commu-
nity. In the present study we evaluated the factors that
influence the occurrence of hyperparasitaemia in children
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presenting with acute, symptomatic, uncomplicated,
P. falciparum malaria in a hyperendemic area of malaria
in southwest Nigeria and describe the risk of hyperparasi-
taemia in these children.
Methods
Patients
The study was carried out between January 2008 and
December 2010 in patients presenting at the Malaria
Clinic at the University College Hospital in Ibadan, an
endemic area for malaria in southwestern Nigeria [10]. In
this area, transmission occurs all year round but is more
intense during the rainy season from April to October.
P. falciparum is the predominant species accounting for
99% of all infections. Children are more affected than
adults, and apparently asymptomatic infections occur in
older school children and adults.
During the study period, all children with febrile ill-
nesses suspected to be or clinically diagnosed as acute fal-
ciparum malaria were enrolled in the study after obtaining
a written informed consent from parents or guardian of
the children. Clinical evaluation consisted of a general
clinical examination including measurement of weight,
core temperature and physical examination. Core tem-
perature was measured orally using an electronic thermo-
meter. In very few young children it was measured
rectally. Ethical clearance was provided by the local ethics
committee.
Drug treatment
Patients with parasitologically proven P. falciparum mono
infections who were not included in 5 antimalarial efficacy
trials (n = 2408) (see below) were treated with amodia-
quine-artesunate and followed for approximately 2-4
weeks. Patients who met the inclusion criteria for enrol-
ment into drug efficacy trials (n = 930) involving artesu-
nate alone, mefoloquine alone, artesunate-mefloquine,
artesunate-amodiaquine and artemether-lumefantrine
were enrolled into these studies and have been reported
elsewhere [11-16].
Assessment of parasitaemia
Thick and thin blood films prepared from a finger prick
were Giemsa-stained and were examined by light micro-
scopy under an oil-immersion objective, at × 1000 magni-
fication, by two independent assessors (microscopists). A
senior member of the study team reviewed the slides if
there was any disagreement between the two microsco-
pists. In addition, one in every four blood slides was
reviewed by this senior member. Parasitaemia in thick
films was estimated by counting asexual parasites relative
to 1000 leukocytes, or 500 asexual forms, whichever
occurred first. From this figure, the parasite density was
calculated assuming a leukocyte count of 6000/mL of
blood. Gametocytes were also counted in thick blood films
against 1000 leukocytes assuming an average leukocyte
count of 6000/mL of blood [17-19]. Haematocrit was done
at enrolment in 1794 children.
Statistical analysis
Data were analysed using version 6 of the Epi-Info soft-
ware [20], and the statistical program SPSS for Windows
version 10.01 [21]. Proportions were compared by calcu-
lating Chi square with Yates’ correction. Normally dis-
tributed, continuous data were compared by Student’s
t-tests and analysis of variance (ANOVA). Data not con-
forming to a normal distribution were compared by the
Mann-Whitney U-test and the Kruskal-Wallis test (or by
Wilcoxon rank sum test). The association between body
temperature and parasite density was assessed by Spear-
man’s correlation coefficient. Semi-log plot of mean para-
site density versus temperature, and the direct plot of log
parasite density versus temperature were examined. The
parasitaemia associated with an increase of 1°C from
37.5°C was determined by calculating the value between
any two temperatures and the difference in parasitaemia
on the semi-log plots and the non-log-transformed para-
sitaemias. A multiple logistic regression model was used
to test the association between hypeparasitaemia (yes or
no at presentation) and factors that were significant at
univariate analysis: age, duration of illness before presen-
tation, and presence of fever (temperature > 37.4°C).
Because the study was conducted over a period of 3
years, time in years since the commencement of study
was included as a covariate in the model. P-values of <
0.05 were taken to indicate significant differences.
Results
During the study period, 6807 children with illnesses sus-
pected to be or diagnosed as malaria were evaluated. Parasi-
taemia was present in 3338 children, a parasite rate of 49%.
The clinical characteristics of the 3338 children enrolled in
the study are summarized in Table 1. Twenty eight percent
of parasite-positive children were aged less than 5 years,
and hyperparasitaemia occurred in 3%. Parasitaemia >
150,000/μl was found in 8% of the children (Table 2).
Relationship between body temperature, fever and
parasitaemia
There was a significant positive correlation between
body temperature and parasitaemia (r = 0.26, P <
0.000001, n = 3175). There was also a significant rela-
tionship between log parasitaemia and body temperature
(Figure 1) such that an increase in parasitaemia of
350,000/μl resulted in a 1°C increase in body tempera-
ture above 37.5°C.
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Factors associated with hyperparasitaemia at
presentation
Factors associated with hyperparasitaemia at enrolment
are presented in Table 3. An age < 11 years, duration of
illness ≤ 3 d, presence of fever, and enrolment after year
2008 were related to the presence of hyperparasitaemia
at enrolment. Neither packed cell volume at presenta-
tion nor season of presentation was related to the pre-
sence of hyperparasitaemia (Table 3).
Risk factors for hyperparasitaemia at presentation
In the multivariable analysis, an age < 11 years, presence
of fever, and enrolment after year 2008 were found to
be independent risk factors for the presence of hyper-
parasitaemia at enrolment (Table 4).
Risk for progression to other forms of severe malaria
Eleven of 3338 children (0.3%) progressed to cerebral
malaria: 7 of these had hyperparasitaemia and 4 had no
hyperparasitaemia. The difference between the two pro-
portions was significant (P < 0.0001, by Fisher exact test).
Seven of the children were < 5 year olds. The risk of pro-
gression was considerably higher in < 5 year olds with
hyperparasitaemia (5 of 30 v 2 of 67 P = 0.02). One of the
3338 children died from cerebral malaria; the child had no
hyperparasitaemia at presentation.
Discussion
Although malaria is major cause of childhood morbidity
and mortality in sub-Saharan Africa and hyperparasitae-
mia is considered a feature of severe malaria [1,2], few
studies from this region have described the risk factors
for hyperparasitaemia in this population. In the current
study, there was clearly a broader age range for suscept-
ibility to hyperparasitaemia-a departure from those of
other forms of severe malaria in African children, for
example, cerebral malaria, where children < 5 year olds
are generally more susceptible.
As was expected, duration of illness < 4 days was
associated with increased risk of hyperparasitaemia. This
relatively short duration is reminiscent of the short
duration of illness for other forms of severe malaria, for
Table 1 Characteristics of children with parasitaemia at
baseline
Parameter Value
No. of children 3338
Female (%) 1591 (48)
Aged < 5 years 938
Febrile (> 37.4°C) 1701
Hyperparasitaemic (> 250,000 (/μl of blood) 97
Anemic (< 30%) 461 (n = 1794)*
(< 15%) 8**
Mean value (range) for:
Age (year) 7.4 (0.16 - 17)
Weight (kg) 21.7 (5 - 71)
Duration of illness (d) 3.2 (1 - 21)
Temperature (°C) 37.7 (35 - 41.1)
Hematocrit (%)
GMPD (/μl of blood)
32.2 (10 - 51)
9440 (750 - 2,250,000)
*24 of 70 children with hyperparasitaemia and 437 of 1724 children without
hyperparasitaemia had a PCV < 30% (P = 0.09).
** 1 of 70 children with hyperparasitaemia and 7 of 1724 children without
hyperparasitaemia had a PCV < 15% (P = 0.27).
Table 2 Distribution of parasitaemia in children enrolled in the study
Period
(year)
No. screened No. positive for P. falciparum Parasite density (/μl of blood)
> 250,000 > 150,000 - 250,000 < 150,000
2008 1956 912 11 39 862
2009 2853 1469 50 77 1342
2010 1998 957 36 56 865
35 36 37 38 39 40 41
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Figure 1 Relationship between parasite density and body
temperature and semi-log plot of mean parasitaemia (at a
particular temperature) versus temperature.
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example, cerebral malaria where a short duration of
illness is the norm [1]. However a short duration of
illness was not an independent risk factor for
hyperparasitaemia.
For two amongst many other reasons, it was surprising
that anemia in under five year-olds, considered a surrogate
marker of malaria disease burden in African children [22],
was not associated with hyperparasitaemia in the cohort of
children evaluated: a parasitaemia > 10,000/μl is a risk fac-
tor for malarial anaemia in children from this endemic
area [23]; malaria is a major cause of anaemia in African
children [24,25]. However, anemia was present in over
25% of cohort of children evaluated-prevalence consider-
ably less than 39% in young children from the same ende-
mic area [23]. The lack of association between anaemia
and hyperparasitaemia may be due to the fact that anae-
mia may be multi-factorial in African children and the
contribution of haemoglobinopathies and malnutrition to
the anemia in these children may be considerable [26-28].
In a study from rural areas of Nigeria, Fasan & Lambo
(1969)[29], and Delfini (1973)[30] found that increases in
body temperature were associated with increasing parasi-
taemia in children with malaria but the relationship
between density and temperature in the individual
patients was not explored. In the present study, there was
a significant relationship between log parasitaemia and
body temperature such that an increase in parasitaemia
of 350,000/μl resulted in a 1°C increase in body tempera-
ture above 37.5°C. This represents a substantial increase
in asexual parasitaemia per unit rise in body temperature
in this cohort of children. Additionally, fever was an
independent risk factor for hyperparasitaemia. Indeed,
children with fever were twice as likely to have a hyper-
parasitaemia compared to children without fever. This
relationship and the associated risk may have been par-
tially attenuated by the prior administration of antipyretic
agents before presentation because approximately 68% of
parents or guardians in this endemic area would give the
antipyretic, acetaminophen, to their children at some
point during a febrile illness before consultation
(Sowunmi, unpublished).
Table 3 Univariable analysis of potential risk factors for
hyperparasitemia in children with Plasmodium falciparum
malaria
Parameter Number of children Crude OR
(95% CI)
P value
Screened HP
Age (year)
> 11 645 6 1 0.0001
≤ 11 2693 91 3.72 (1.62-8.54)
Gender
Male 1729 52 1 0.83
Female 1591 45 1.06 (0.71 - 1.59)
Duration (d)
> 3 677 10 1 0.013
≤ 3 2406 78 2.23 (1.15 - 4.34)
Temp (°C)
< 37.5 1474 25 1 0.001
≥ 37.5 1701 63 2.22 (1.39 - 3.56)
Haematocrit (%)
< 30 461 24 1 0.09
≥ 30 1333 46 1.53 (0.92 - 2.54)
Year of enrolment
during 2008 912 11 1 0.0001
After 2008 2426 86 3.01 (1.60 - 5.66)
Season*
Wet 2540 79 1 0.22
Dry 798 18 1.39 (0.82 - 2.33)
*Wet season, April to October; dry season, November to March
Table 4 Multivariable analysis of independent risk factors for hyperparasitaemia in children with Plasmodium
falciparum malaria
Parameter Total No. No. with HP Crude OR
(95% CI)
P value Adjusted OR
(95% CI)
P value
Age (year)
> 11 645 6 1 0.0001 1 0.014
≤ 11 2693 91 3.72 (1.62-8.54) 2.85 (1.23-6.61)
Duration (d)
> 3 677 10 1 0.013 1 0.07
≤ 3 2406 78 2.23 (1.15 - 4.34) 1.85 (0.94 - 3.63)
Temp (°C)
< 37.5 1474 25 1 0.001 1 0.005
≥ 37.5 1701 63 2.22 (1.39 - 3.56) 2.02 (1.23 - 3.29)
Year of enrolment
during 2008 912 11 1 0.0001 1 0.001
After 2008 2426 86 3.01 (1.60 - 5.66) 3.07 (1.57 - 5.99)
HP, hyperparasitaemia (asexual parasites > 250,000/μl of blood)
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In contradistinction to the finding in an area of lesser
intensity of transmission, for example, on the Thai-
Burmese border, where hyperparasitaemia is associated
with the dry season [31], there was no association between
season and the risk of hyperparasitaemia in this area of
intense transmission. The reasons for the lack of associa-
tion in the present study are unclear but more studies are
required. It is also intriguing that enrolment after 2008 was
an independent risk factor for hyperparasitaemia. There is,
as yet, no ready explanation for this observation.
All the possible risk factors for hyperparasitaemia were
not captured in the present study. Recent histories of
diarrhoea and the presence of gametocytes, a finding
associated with hyperparasitaemia in Thailand [9], for
examples, were not considered. Nevertheless, a large
number of children were evaluated. Hyperparasitaemia
was associated with increased risk of progression to cere-
bral malaria suggesting that hyperparasitaemia should
not be considered as variabe depending on epidemiology
setting in childhood malaria as was done in the original
WHO document [1] but be retained as a component of
severe malaria at all times in children < 5 years. Thus,
the results described in this study population should have
significance in shaping the diagnosis of and guidelines for
the management of hyperparasitaemia in children in
African setting.
Conclusion
In conclusion, a relatively broader age range, fever and
enrolment after year 2008 are independent risk factors
for hyperparasitaemia in malarious children in this
endemic area. Hyperparasitaemia is significantly asso-
ciated with an increased risk of progression to cerebral
malaria in young children < 5 years old.
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